NeuroSense Therapeutics Net Worth
NeuroSense Therapeutics Net Worth Breakdown | NRSNW |
NeuroSense Therapeutics Net Worth Analysis
NeuroSense Therapeutics' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including NeuroSense Therapeutics' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of NeuroSense Therapeutics' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform NeuroSense Therapeutics' net worth analysis. One common approach is to calculate NeuroSense Therapeutics' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares NeuroSense Therapeutics' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing NeuroSense Therapeutics' net worth. This approach calculates the present value of NeuroSense Therapeutics' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of NeuroSense Therapeutics' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate NeuroSense Therapeutics' net worth. This involves comparing NeuroSense Therapeutics' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into NeuroSense Therapeutics' net worth relative to its peers.
To determine if NeuroSense Therapeutics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding NeuroSense Therapeutics' net worth research are outlined below:
| NeuroSense Therapeutics is way too risky over 90 days horizon | |
| NeuroSense Therapeutics has some characteristics of a very speculative penny stock | |
| NeuroSense Therapeutics appears to be risky and price may revert if volatility continues | |
| NeuroSense Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (11.28 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NeuroSense Therapeutics Ltd has accumulated about 994 K in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13. | |
| NeuroSense Therapeutics has a frail financial position based on the latest SEC disclosures |
NeuroSense Therapeutics Earnings per Share Projection vs Actual
NeuroSense Therapeutics Corporate Management
| Yael Barak | VP Compliance | Profile | |
| Ferenc Tracik | Chief Officer | Profile | |
| Or Eisenberg | Chief Officer | Profile | |
| Alon BenNoon | CEO CoFounder | Profile | |
| Hagit Binder | Chief Officer | Profile | |
| Oron DVM | Chief Officer | Profile | |
| Ferenc MD | Chief Officer | Profile |
Additional Tools for NeuroSense Stock Analysis
When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.